MANKIND price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- MANKIND
- MB Code
- MBEQU1587
- ISIN
- INE634S01028
- BSE code
- 543904
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 3442.93 Cr
- Net profit
- 559.42 Cr
- EPS
- 13.41
- YoY revenue
- +11.81%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for MANKIND
EPS 13.97 vs est. 10.85
Beat estimates by 28.72%
Mankind Pharma’s Q4FY26 profit rose 30.4% on stronger domestic demand, led by chronic therapies and OTC healthcare products, signaling so…
Mankind Pharma reported Q4 revenue up 11.8% to ₹3,443 crore, EBITDA up 36.1% and margin at 27%; India sales grew 13% on chronic therapy s…
EPS 12.47 vs est. 12.39
Beat estimates by 0.62%
EPS 12.38 vs est. 13.97
Missed estimates by 11.41%
Dividend of ₹1.00 per share
Ex-date corporate action
Mankind Pharma shares rose 4.93% to Rs 2,669.50, showing strong momentum today with increased trading volume, making it one of the top ga…
Stay updated with the latest news and announcements from Mankind Pharma, including stock quotes and market insights from The Economic Times.
Price returns
Historical performance
Technicals
Indicator consensus